RT Journal Article
SR Electronic
A1 Buckley, Rita
T1 Combined Intensive BP and Glycemic Control Has No Benefit in Reducing CV Risk in Patients with T2DM
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 11
SP 15
OP 15
DO 10.1177/155989771111009
UL http://mdc.sagepub.com/content/11/11/15.1.abstract
AB The Action to Control Cardiovascular Risk in Diabetes [ACCORD] study was a randomized, multicenter clinical trial [NCT00000620] that was conducted in 77 clinical sites in the United States and Canada. None of the ACCORD prespecified microvascular outcomes was significantly reduced in participants who were intensively treated for both glycemia and BP compared with those who were treated with either regimen alone, signifying the lack of an additional beneficial effect from combined intensive treatment.